Safety and Efficacy Study Comparing a New hMG Formulation (hMG-IBSA) to a Reference Product (Menopur[Rm]) in Patients Undergoing Ovarian Stimulation for in Vitro Fertilisation (IVF).

Trial Profile

Safety and Efficacy Study Comparing a New hMG Formulation (hMG-IBSA) to a Reference Product (Menopur[Rm]) in Patients Undergoing Ovarian Stimulation for in Vitro Fertilisation (IVF).

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Dec 2016

At a glance

  • Drugs Menotropin (Primary)
  • Indications Infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 13 Mar 2012 Planned End Date changed from 1 Dec 2012 to 1 Oct 2013 as reported by ClinicalTrials.gov.
    • 15 Dec 2011 Planned end date changed from 1 Sep 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top